Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

Share Price Information for Microsaic (MSYS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.00
Bid: 0.95
Ask: 1.05
Change: 0.00 (0.00%)
Spread: 0.10 (10.526%)
Open: 1.00
High: 1.00
Low: 1.00
Prev. Close: 1.00
MSYS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Supply of mass spectroscopy services to DeepVerge

13 Sep 2022 07:25

RNS Number : 2401Z
Microsaic Systems plc
13 September 2022
 

Microsaic Systems plc

("Microsaic" or the "Company")

 

Microsaic to supply mass spectrometry services to DeepVerge

Microsaic Systems plc (AIM: MSYS), is pleased to note the announcement published by DeepVerge Group plc ("DeepVerge") earlier today, regarding its two-year environmental monitoring and remediation project with MèreMer for its Blue Carbon Resilience Flagship project (the "Project"). The full text of the DeepVerge announcement is available here: https://www.londonstockexchange.com/news-article/DVRG/blue-carbon-resilience-project/15625889.

 

As part of the Project, DeepVerge will appoint Microsaic as its partner to carry out the related mass spectroscopy-based sample analysis. It is expected that the provision of these services will begin in or after October 2022.

 

Whilst subject to contract, it is currently expected that the total value of goods and services to be provided by Microsaic will be approximately £200k, the significant majority of which will be recognised in FY23 (the next financial year).

 

Certain transactions between Microsaic and DeepVerge could constitute related party transactions under Rule 13 of the AIM Rules for Companies and as such, further regulatory announcements will be made in due course as appropriate.

 

Enquiries: 

Microsaic Systems plc

+44 (0) 734 0055 648

Gerry Brandon, Executive Chairman

Singer Capital Markets (Nominated Adviser & Joint Broker)

+44 (0)20 7496 3000

Aubrey Powell / George Tzimas (Corporate Finance)

Turner Pope Investments (TPI) Limited  (Joint Broker)

Andy Thacker  /  James Pope

+44 (0) 20 3657 0050

 

About Microsaic Systems

Microsaic has over 20 years' experience in microelectronics and development of instrumentation. The Company has a robust and innovative patent portfolio in cutting-edge technology designed and developed for "Industry 4.0" application serving markets in diversified Industries, Human and Environmental Health. Microsaic's system solutions have enabled analytical detection and characterisation at the point-of-need, whether within a conventional laboratory setting, or within a bioprocessing facility for continuous detection of data at multiple steps in the process workflow.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGLGDCGDBDGDX
Date   Source Headline
11th Aug 20209:30 amRNSForm 8.5 (EPT/RI)
10th Aug 20204:33 pmBUSForm 8.3 - Microsaic Systems
10th Aug 202010:08 amRNSForm 8.5 (EPT/RI)
7th Aug 20204:59 pmRNSForm 8.3 - Microsaic Systems PLC
7th Aug 20209:14 amRNSForm 8.5 (EPT/RI)
6th Aug 202012:07 pmRNSForm 8.5 (EPT/RI)
5th Aug 202010:04 amRNSForm 8.5 (EPT/RI)
4th Aug 20202:31 pmRNSForm 8.3 - Microsaic Systems PLC
4th Aug 202011:39 amRNSForm 8.5 (EPT/RI)
3rd Aug 20201:54 pmRNSForm 8.3 - Microsaic Systems plc
3rd Aug 202011:24 amRNSForm 8.5 (EPT/RI)
31st Jul 20204:06 pmRNSForm 8 (OPD) Microsaic Systems plc
31st Jul 20201:43 pmRNSForm 8.3 - Microsaic Systems plc
31st Jul 20209:37 amRNSForm 8.5 (EPT/RI)
31st Jul 20209:11 amRNSForm 8.3 - Microsaic Systems plc
30th Jul 20204:03 pmRNSParkwalk Advisors: Form 8.3- Microsaic Systems plc
30th Jul 202011:47 amRNSForm 8.5 (EPT/RI)
29th Jul 20205:48 pmGNWForm 8.3 - Microsaic Systems plc
29th Jul 202012:00 pmRNSForm 8.3 - Microsaic Systems plc
29th Jul 20207:00 amRNSStrategic Review and Formal Sale Process
25th Jun 20203:16 pmRNSResult of AGM
1st Jun 20207:00 amRNSPosting of Annual Report and Notice of AGM
7th May 20207:00 amRNSCOVID-19 Update
9th Mar 20207:00 amRNSFinal Results
3rd Mar 20207:00 amRNSAppointment of WH Ireland as Joint Broker
26th Feb 20207:00 amRNSGlobal collaboration agreement with Axcend Corp
16th Jan 20207:00 amRNSPre-close Trading Update
16th Dec 20197:00 amRNSMicrosaic collaborates with the CPI
6th Dec 20194:35 pmRNSPrice Monitoring Extension
5th Dec 20199:05 amRNSSecond Price Monitoring Extn
5th Dec 20199:00 amRNSPrice Monitoring Extension
5th Dec 20197:00 amRNSExclusive Japan Distribution Agreement
13th Nov 20194:41 pmRNSSecond Price Monitoring Extn
13th Nov 20194:35 pmRNSPrice Monitoring Extension
26th Sep 20194:35 pmRNSPrice Monitoring Extension
23rd Sep 20197:00 amRNSInterim Results
4th Sep 20197:00 amRNSNotice of Results
12th Jun 20191:38 pmRNSAward of options
7th Jun 20197:00 amRNSDistribution Agreement with CM Corporation Ltd.
3rd Jun 20197:00 amRNSCost and time savings in manufacture of biologics
16th May 20192:06 pmRNSBoard Change
14th May 201912:00 pmRNSResult of AGM
14th May 201911:05 amRNSSecond Price Monitoring Extn
14th May 201911:00 amRNSPrice Monitoring Extension
14th May 20197:00 amRNSAGM Statement
2nd May 20197:00 amRNSDeepened collaboration with Chinese partner
12th Apr 20197:00 amRNSNotice of AGM and Posting of Annual Report
18th Mar 20197:00 amRNSOEM Agreement
11th Mar 20197:00 amRNSFinal Results
5th Mar 20197:00 amRNSMSYS jointly publishes bioprocessing data with MIT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.